Young adult leukemia, lymphoma survivors more distressed than older survivors
the ONA take:
According to two new studies published in the Journal of Psychosocial Oncology, researchers from University of Colorado Cancer Center in Denver, Colorado, have found that young adult survivors of leukemia and lymphoma are more likely to report high stress compared with older survivors of the same diseases.
Specifically, researchers found that 45% of patients aged 18-39 years old reported moderate-to-high distress, while 18% of those over 65 years reported the same level of distress. Neither group's distress was affected by time since cancer treatment.
The first study surveyed 477 cancer survivors. Researchers found that survivors under age 40 had the highest prevalence of distress, mostly due patients' fear of cancer recurrence. Survivors were also concerned with the high financial burden.
The second study interviewed 51 survivors of leukemia to better understand their reasons for high distress. Some patients were concerned about the financial burden, while others stressed about how long it would take to fully recover both physically and mentally.
The findings reinforce the importance of identifying those who are most likely to experience elevated stress levels and to understand their reasons for concern so that targeted interventions can be implemented.
Young adult survivors of leukemia and lymphoma are more likely to report high stress compared with older survivors of the same diseases.
- Physical Activity Improves Outcomes for Patients with Breast Cancer and Survivors
- Behavior Pain Assessment Tool Measures Pain In Patients Who Cannot Communicate Verbally
- Whole Genome Sequencing Reveals that 12% of Childhood Cancer Survivors Have Mutations in Genes that Increase Cancer Risk
- Novel Test For Multiple Myeloma Uses Microchip, Conventional Blood Sample
- Increased 5-Year Survival Rate Seen in NSCLC Subset Treated With Nivolumab
- Exercise, Psychological Interventions Better for Cancer Fatigue Than Medications
- ASCO Issues Global Guidance for HPV Vaccination for Cervical Cancer Prevention
- Discharge Events Improved With Standardized Inpatient Palliative Care Consultation
- Little Opposition to Early Palliative Care for Symptom Management in Pediatric Oncology
- Updated ASTRO Guideline Bolsters Safety, Efficacy of Palliative RT for Bone Metastases
- Thyroid Cancer Incidence Increasing Among Younger, Hispanic, African American Populations
- JAK1, JAK2 Inhibition Improves Outcomes in Myeloproliferative Neoplasms, But More Is Needed
- Recommendations Against Contralateral Prophylactic Mastectomy Not Tied to Patient Satisfaction
- Self-efficacy Level Predictive of Likelihood to Follow Through With Colorectal Cancer Screening
- Chronic Myeloproliferative Neoplasms Treatment (Fact Sheet)
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|